Cargando…
Current status of and strategies for hepatitis C control in South Korea
Chronic hepatitis C (CHC) is caused by hepatitis C virus (HCV) infection. HCV infection causes acute hepatitis, and the majority of those infected progress to chronic hepatitis, and some of them develop cirrhosis and hepatocellular carcinoma. Transmission of HCV is parenteral, and the major transmis...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628002/ https://www.ncbi.nlm.nih.gov/pubmed/28942625 http://dx.doi.org/10.3350/cmh.2017.0105 |
_version_ | 1783268812843384832 |
---|---|
author | Kim, Beom Kyung Jang, Eun Sun Kim, Jeong Han Park, Soo Young Ahn, Song Vogue Kim, Hyung Joon Kim, Do Young |
author_facet | Kim, Beom Kyung Jang, Eun Sun Kim, Jeong Han Park, Soo Young Ahn, Song Vogue Kim, Hyung Joon Kim, Do Young |
author_sort | Kim, Beom Kyung |
collection | PubMed |
description | Chronic hepatitis C (CHC) is caused by hepatitis C virus (HCV) infection. HCV infection causes acute hepatitis, and the majority of those infected progress to chronic hepatitis, and some of them develop cirrhosis and hepatocellular carcinoma. Transmission of HCV is parenteral, and the major transmission routes include drug abuse, insecure injections or medical procedures, contaminated syringes or needles, sexual contact with an HCV-infected person, vertical infection of newborns by infected mothers, the transfusion of blood or blood products contaminated with viruses, and organ transplants. As no vaccine against HCV is available, HCV management involves blocking routes of transmission transmission, screening for HCV infection, and protecting liver disease progression by treatment. Highly potent oral direct antiviral agents are now available. Therefore, early detection through nation-wide screening program and appropriate treatment should be implemented to improve the quality of life of patients with HCV. Furthermore, for the effective HCV control in South Korea, The organization of an ‘integrated national viral hepatitis control system’ is desirable. |
format | Online Article Text |
id | pubmed-5628002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Association for the Study of the Liver |
record_format | MEDLINE/PubMed |
spelling | pubmed-56280022017-10-06 Current status of and strategies for hepatitis C control in South Korea Kim, Beom Kyung Jang, Eun Sun Kim, Jeong Han Park, Soo Young Ahn, Song Vogue Kim, Hyung Joon Kim, Do Young Clin Mol Hepatol Review Chronic hepatitis C (CHC) is caused by hepatitis C virus (HCV) infection. HCV infection causes acute hepatitis, and the majority of those infected progress to chronic hepatitis, and some of them develop cirrhosis and hepatocellular carcinoma. Transmission of HCV is parenteral, and the major transmission routes include drug abuse, insecure injections or medical procedures, contaminated syringes or needles, sexual contact with an HCV-infected person, vertical infection of newborns by infected mothers, the transfusion of blood or blood products contaminated with viruses, and organ transplants. As no vaccine against HCV is available, HCV management involves blocking routes of transmission transmission, screening for HCV infection, and protecting liver disease progression by treatment. Highly potent oral direct antiviral agents are now available. Therefore, early detection through nation-wide screening program and appropriate treatment should be implemented to improve the quality of life of patients with HCV. Furthermore, for the effective HCV control in South Korea, The organization of an ‘integrated national viral hepatitis control system’ is desirable. The Korean Association for the Study of the Liver 2017-09 2017-09-19 /pmc/articles/PMC5628002/ /pubmed/28942625 http://dx.doi.org/10.3350/cmh.2017.0105 Text en Copyright © 2017 by The Korean Association for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Kim, Beom Kyung Jang, Eun Sun Kim, Jeong Han Park, Soo Young Ahn, Song Vogue Kim, Hyung Joon Kim, Do Young Current status of and strategies for hepatitis C control in South Korea |
title | Current status of and strategies for hepatitis C control in South Korea |
title_full | Current status of and strategies for hepatitis C control in South Korea |
title_fullStr | Current status of and strategies for hepatitis C control in South Korea |
title_full_unstemmed | Current status of and strategies for hepatitis C control in South Korea |
title_short | Current status of and strategies for hepatitis C control in South Korea |
title_sort | current status of and strategies for hepatitis c control in south korea |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628002/ https://www.ncbi.nlm.nih.gov/pubmed/28942625 http://dx.doi.org/10.3350/cmh.2017.0105 |
work_keys_str_mv | AT kimbeomkyung currentstatusofandstrategiesforhepatitisccontrolinsouthkorea AT jangeunsun currentstatusofandstrategiesforhepatitisccontrolinsouthkorea AT kimjeonghan currentstatusofandstrategiesforhepatitisccontrolinsouthkorea AT parksooyoung currentstatusofandstrategiesforhepatitisccontrolinsouthkorea AT ahnsongvogue currentstatusofandstrategiesforhepatitisccontrolinsouthkorea AT kimhyungjoon currentstatusofandstrategiesforhepatitisccontrolinsouthkorea AT kimdoyoung currentstatusofandstrategiesforhepatitisccontrolinsouthkorea |